Pages:
- A Sitemap for LambLawOffice.com
- About Our Firm
- Alabama: Medical Records Copying Charges Law / Statute
- Alaska: Medical Records Copying Charges Law / Statute
- Archive
- Arizona: Medical Records Copying Charges Law / Statute
- Arkansas: Medical Records Copying Charges Law / Statute
- Asbestos & Mesothelioma Overview
- Asbestos Claims: How Do I Get Legal Compensation?
- Attorney Profile: Thomas J. Lamb
- Benzene Cancer Resources
- Benzene Case Evaluation Form
- Benzene Cases Overview
- Benzene Exposure
- Benzene Exposure and AML
- Benzene Exposure and MDS
- Benzene Exposure in Industries
- Benzene-Containing Products
- Benzene-Related Diseases
- Benzene: Frequently Asked Questions
- Blog
- Breast Implant and Lymphoma: Resources
- Breast Implant and Lymphoma: Summary of Information
- Breast Implants and Lymphoma FAQs: About the Disease
- Breast Implants and Lymphoma FAQs: Prognosis
- Breast Implants and Lymphoma FAQs: Risk Factors
- Breast Implants and Lymphoma FAQs: Symptoms
- Breast Implants and Lymphoma FAQs: Treatment
- Breast Implants and Lymphoma: FDA Information
- Breast Implants and Lymphoma: Frequently Asked Questions
- Breast Implants and Lymphoma: The Disease
- Breast Implants Cancer Case Evaluation Form
- Breast Implants Cases Overview
- California: Medical Records Copying Charges Law / Statute
- Case Evaluation Explanation
- Case Evaluation Menu
- Class Action vs. Individual Lawsuits
- Colorado: Medical Records Copying Charges Law / Statute
- Connecticut: Medical Records Copying Charges Law / Statute
- Contact Us
- Current Drug Injury Litigations
- Delaware: Medical Records Copying Charges Law / Statute
- Directions to Our Office at Lumina Station
- Disclaimer and Copyright Notices
- District of Columbia: Medical Records Copying Charges Law / Statute
- Drug Injury Cases Overview
- ED Drugs (as well as BPH and PAH drugs)
- Florida: Medical Records Copying Charges Law / Statute
- Frequently Asked Questions
- General Case Evaluation Form
- GenX Cancer Case Evaluation Form
- GenX Cancers Overview
- GenX Contamination of Fayetteville Well Water: Who is at Risk?
- GenX Research Sources
- Georgia: Medical Records Copying Charges Law / Statute
- Hawaii: Medical Records Copying Charges Law / Statute
- Heartburn and Acid Reflux Drugs
- Hepatitis C Treatment Drugs – DAAs
- How Payment for Our Legal Services Works
- How to File a Benzene Workers Compensation Claim in NC
- Idaho: Medical Records Copying Charges Law / Statute
- Illinois: Medical Records Copying Charges Law / Statute
- Incretin Mimetic Drugs
- Indiana: Medical Records Copying Charges Law / Statute
- Iowa: Medical Records Copying Charges Law / Statute
- Kansas: Medical Records Copying Charges Law / Statute
- Kentucky: Medical Records Copying Charges Law / Statute
- Lamb Law Blog
- Learn More About How We Work
- Louisiana: Medical Records Copying Charges Law / Statute
- Maine: Medical Records Copying Charges Law / Statute
- Maryland: Medical Records Copying Charges Law / Statute
- Massachusetts: Medical Records Copying Charges Law / Statute
- Medical Records Copying Charges
- Medical Records Costs Update 2020: 21st Century Cures Act Amends “Patient Rates” Aspect of HITECH
- Mesothelioma and Asbestos Lawsuits
- Mesothelioma, Asbestos, and Legal Compensation: Basic Facts
- Michigan: Medical Records Copying Charges Law / Statute
- Minnesota: Medical Records Copying Charges Law / Statute
- Mississippi: Medical Records Copying Charges Law / Statute
- Missouri: Medical Records Copying Charges Law / Statute
- Montana: Medical Records Copying Charges Law / Statute
- NC Workers Compensation Benzene Disease Claims Filing Deadline
- Nebraska: Medical Records Copying Charges Law / Statute
- Nevada: Medical Records Copying Charges Law / Statute
- New Hampshire: Medical Records Copying Charges Law / Statute
- New Jersey: Medical Records Copying Charges Law / Statute
- New Mexico: Medical Records Copying Charges Law / Statute
- New York: Medical Records Copying Charges Law / Statute
- North Carolina: Medical Records Copying Charges Law / Statute
- North Dakota: Medical Records Copying Charges Law / Statute
- Ohio: Medical Records Copying Charges Law / Statute
- Oklahoma: Medical Records Copying Charges Law / Statute
- Oregon: Medical Records Copying Charges Law / Statute
- Our Investigation of Your Case
- Pennsylvania: Medical Records Copying Charges Law / Statute
- Practice Areas
- Quick Contact Form
- Reporting Adverse Drug Reactions To The FDA MedWatch Program
- Resources: Legal, Medical, and More
- Rhode Island: Medical Records Copying Charges Law / Statute
- September 2017: New GenX Information Soon to be Released
- Sitemap for All Website Pages
- South Carolina: Medical Records Copying Charges Law / Statute
- South Dakota: Medical Records Copying Charges Law / Statute
- Tennessee: Medical Records Copying Charges Law / Statute
- Texas: Medical Records Copying Charges Law / Statute
- Thank You For Allowing Us To Review Your Possible Case
- Thank You for Completing Our Form
- Thomas J. Lamb – Drug Injury, Asbestos Mesothelioma, Benzene Cancers
- Timeline: GenX Contamination of the Cape Fear River
- Timeline: GenX Study Results
- Type 2 Diabetes Drugs (DPP-4 Inhibitors)
- Type 2 Diabetes Drugs (SGLT-2 Inhibitors)
- Utah: Medical Records Copying Charges Law / Statute
- Vermont: Medical Records Copying Charges Law / Statute
- Virginia: Medical Records Copying Charges Law / Statute
- Washington: Medical Records Copying Charges Law / Statute
- We Will Not Pressure or Rush You to Sign Our Contract of Representation
- West Virginia: Medical Records Copying Charges Law / Statute
- What are Mesothelioma, Asbestos Lung Cancer, and Asbestosis?
- What is Asbestos?
- What We Know About GenX
- While We Are Working on Your Case
- Wisconsin: Medical Records Copying Charges Law / Statute
- Workers Who Could Be Exposed to Benzene
- Wyoming: Medical Records Copying Charges Law / Statute
- Your Drug Injury Case Review
Categories:
Authors:
- Legal Assistant (1)
- Thomas Lamb (524)
Monthly:
- April 2021
- March 2021
- February 2021
- January 2021
- December 2020
- November 2020
- October 2020
- September 2020
- August 2020
- July 2020
- June 2020
- May 2020
- April 2020
- March 2020
- February 2020
- January 2020
- December 2019
- November 2019
- October 2019
- September 2019
- August 2019
- July 2019
- June 2019
- May 2019
- April 2019
- March 2019
- February 2019
- January 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- February 2018
- January 2018
- December 2017
- November 2017
- October 2017
- September 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- November 2016
- October 2016
- September 2016
- August 2016
- July 2016
Recent Posts:
- Incidence of mesothelioma and asbestosis by occupation in a diverse workforce
- There Will Be No Belviq Generic Drugs After Belviq Drug Recall in 2020
- Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study
- Anti-Mesothelin CAR T cell therapy for malignant mesothelioma
- Testing Shows High Levels of Benzene Found In Hand Sanitizers
- Are Heart Problems and Cancers JAK Inhibitors Drug Class Safety Issues?
- New EPA Administrator Makes PFAS Contamination Issue A Priority
- Effect of Asbestos Exposure on the Frequency of EGFR Mutations and ALK/ROS1 Rearrangements in Patients With Lung Adenocarcinoma: A Multicentric Study
- New Elmiron Medication Guide Points Out Retinal Pigmentary Eye Problems
- What is the link between asbestos and lung cancer?
- Survival of patients with asbestosis can be assessed by risk-predicting models
- Beovu Lawsuits Lawyer / Law Firm Handles Individuals’ Cases, Not Beovu Class Actions
- Some Information About Our Monthly Law Firm Newsletter
- Malignant Pleural Mesothelioma Clinical Practice Guidelines (SEOM, 2021)
- Elmiron Can Double the Risk of Pigmentary Maculopathy or Macular Degeneration
- Study seeks to identify biological markers that predict mesothelioma response to treatment
- New Xeljanz Warnings From FDA in 2021; Are Other JAK Inhibitors Next?
- First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial
- Xeljanz 2021 FDA Warnings: Xeljanz Causing Heart Problems and Xeljanz Causing Cancer
- New Options Spark Sequencing and Biomarker Trials in Mesothelioma
- Bristol’s Opdivo scores again in tough-to-treat mesothelioma, this time flying solo
- Beovu Side Effects and Beovu Lawsuits for Patients Complicate Future for Beovu
- Notice Violation Issued to Chemours After Failure to Properly Remove PFAS Contamination
- Cell and extracellular matrix interaction models in benign mesothelial and malignant pleural mesothelioma cells in 2D and 3D in‐vitro
- Maculopathy Patients Should be Asked About Any Elmiron Use in Past
- Gilenya Label Change with New Liver Injury Risk Warnings in Canada
- Surgery for malignant pleural mesothelioma after radiotherapy (SMART): final results from a single-centre, phase 2 trial
- Talc-Based Beauty Products Found to be Contaminated With Asbestos
- Elmiron Legal Cases for Eye Damage and Retinal Injury Are Consolidated in Elmiron MDL
- Additional PFAS Testing Petition Denied by the EPA
- Beovu: What Comes Next for This Troubled Novartis AMD Eye Injection?
- Elmiron Updates: Legal, Medical, and Regulatory – December 2020
- BIA-ALCL Case Studies Confirm Importance of Proper Treatment
- Beovu Retinal Vasculitis Made Worse by a Later Lucentis Treatment
- Beovu-related Retinal Vasculitis and Beovu Vision Loss Cases
- Chemo-Free Regimen Boosts OS in Mesothelioma
- Beovu Injections Side Effects: Novartis Points Out Risk Factors and Possible Causes in November 2020 Report
- Dying Patients Denied Justice Amid COVID-Related Court Delays
- Gilenya Linked To Acute Liver Failure, Drug-induced Liver Injury
- PFAS Levels in Cape Fear Remain Largely the Same, Despite Emission Cuts
- Mesothelioma risk among those exposed to chrysotile asbestos only and mixtures that include amphibole: a case–control study in the USA, 1975–1980
- Beovu Legal Cases: Compensation for Eye Problems from Beovu Use
- Global Picato Recall Due to Picato Skin Cancer Risk Findings Update
- Stelara-associated Cardiovascular Events: Emerging Drug Safety Issue
- Black Box Warning Label Change for Breast Implants Finalized by the FDA
- Biomarker candidates could aid in earlier diagnosis of mesothelioma
- Ocaliva Drug Label Warnings vis-à-vis FDA Ocaliva Safety Signal Investigation
- A multicentre randomised phase III trial comparing pembrolizumab vs single-agent chemotherapy for advanced pre-treated malignant pleural mesothelioma: the European Thoracic Oncology Platform (ETOP 9-15) PROMISE-meso trial
- Current Ocaliva Liver Safety FDA Evaluation Started Back in May 2020
- FDA Approves Drug Combination for Treating Mesothelioma
- Beovu-associated Endophthalmitis is “New” for Beovu Eye Drug Safety Issue of Vision Loss
- Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in
- Beovu Use Continues Despite Ongoing Beovu-associated Inflammation Investigation
- Safety of Beovu Update: Study Results Announcement by Novartis and Beovu Label Change in Europe
- FDA clears IND application for CAR T-cell therapy for advanced mesothelioma
- FDA Belviq Recall Decision Came After Safety Data Review Found Excess Cancers Risks
- Phase I Study of Novel Drug Shows Preliminary Activity in Mesothelin-Expressing Tumors
- Are Elmiron Side Effects Risks for Eye and Vision Are Greater Than Its Bladder Treatment Benefits?
- Chemours GenX Contamination Case Reaches New Deal
- Elmiron Lawsuits Being Filed Against Drug Companies for Elmiron-Related Eye Problems
- Telomerase reverse transcriptase promoter mutations identify a genomically defined and highly aggressive human pleural mesothelioma subgroup
- New BIA-ALCL Cases Identified in Updated FDA Report
- Chemical Firm BASF and Its Law Firm to Pay $72.5M to Close Talcum-Asbestos Claims
- VEGF Inhibitors Class Of Drugs: Risks Of Aneurysm And Artery Dissection
- Clinical Practice Guidelines for the Management of Malignant Pleural Mesothelioma
- Nivolumab/Ipilimumab Demonstrates Durable OS Benefit in Malignant Pleural Mesothelioma
- After Two Injections Of Beovu, Retinal Vasculitis With Vision Loss
- Private Settlement Reached in Mesothelioma Case
- Beovu | July 2020 | Current Findings For Occlusive Vasculitis And Vision Loss
- PFAS Contamination of the Cape Fear Still An Issue
- Most American Women Are Unaware of BIA-ALCL
- Questioning the prognostic role of BAP-1 immunohistochemistry in malignant pleural mesothelioma: A single center experience with systematic review and meta-analysis
- When Will FDA Weigh-in On The Picato Skin Cancer Safety Issue?
- Study finds drug beneficial for shrinking mesothelioma tumors
- Beovu: External Safety Review Committee Findings Lead To New Vision-Related Side Effects Warnings
- [Transforming Growth Factor Alpha] Promotes Chemoresistance of Malignant Pleural Mesothelioma
- Allergan Aesthetics Launches Tracking Campaign for U.S. Breast Implant Patients
- New Beovu Warnings About Risks Of Retinal Vasculitis And Retinal Vascular Occlusion
- Johnson & Johnson to stop selling talc baby powder in U.S. and Canada
- Zantac Recall: Chemical NDMA In Zantac Pills Can Cause Cancers
- Chemours’ PFAS Chemical Reduction Plans: Are They Enough?
- Imerys signs agreement to end talc litigation in the United States
- After Drug Recall Belviq Lawsuits Alleging Failure To Warn About Cancer
- A dying wish for schools
- Advances Made in Understanding and Treatment of BIA-ALCL
- Lemtrada Side Effects Now Include Lemtrada Causing ANCA-Associated Vasculitis
- Bristol Myers Squibb’s Opdivo-Yervoy combo helps mesothelioma patients live longer
- Picato Skin Cancer Risk Confirmed In Europe; FDA Picato Review Ongoing
- Asbestos inhalation poses cancer risks to workers and consumers
- Beovu Vision Loss And Retinal Vasculitis Cases May Lead To New Warnings
- EPA finds asbestos poses cancer risks for workers, reigniting calls for ban
- Comparative analysis of prognostic histopathologic parameters in subtypes of epithelioid pleural mesothelioma
- Xeljanz Side Effects Include Blood Clots, Pulmonary Embolism, And Serious Infections
- Montana Supreme Court: BNSF Not Shielded from Liability in Libby Asbestos Cases
- Asbestos Warnings Grow With Penn State Lawsuit, National Push
- Lemtrada-Related Cardiovascular Reactions And Immune-Mediated Reactions
- The Role of Neoadjuvant Chemotherapy in Patients with Resectable Malignant Pleural Mesothelioma – An Institutional and National Analysis
- Malignant mesothelioma of the tunica vaginalis testis: a rare case and review of literature
- Beovu Warning For Retinal Vasculitis: Is Current Drug Label Sufficient “As Is”?
- Philly School District poised to pay $850K to teacher diagnosed with mesothelioma